Recombinant TNFRSF10B (Drozitumab Biosimilar) 抗体
The 小鼠 单克隆 anti-TNFRSF10B (Drozitumab Biosimilar) antibody (ABIN7795105) specifically detects TNFRSF10B (Drozitumab Biosimilar) in FACS 和 in vivo.
The antibody is reactive with 人 samples.
产品编号 ABIN7795105
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for Recombinant TNFRSF10B (Drozitumab Biosimilar) 抗体 (ABIN7795105)
抗原
TNFRSF10B (Drozitumab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
小鼠
克隆类型
单克隆
标记
This TNFRSF10B (Drozitumab Biosimilar) antibody is un-conjugated
应用范围
Flow Cytometry (FACS), In vivo Studies (in vivo)
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Drozitumab Biosimilar, TRAIL Monoclonal Antibody
-
产品特性
- Drozitumab Biosimilar uses the same protein sequences as the therapeutic antibody drozitumab. Drozitumab is a human monoclonal antibody in development for the treatment of cancers. It targets Tumour Necrosis Factor Related Apoptosis-inducing Ligand (TRAIL), whose receptors are found on the surface of many types of malignant cells. Although drozitumab was studied in phase II trials for treating chondrosarcoma, colorectal cancer, non-Hodgkin lymphoma, and non-small cell lung cancer, development has been halted due to lack of clinical response.
-
纯化方法
- Protein A or G affinity column
-
纯度
- >95 % by reducing SDS-PAGE
-
内毒素水平
- < 1 EU per 1 mg of the protein by the LAL method
-
免疫原
- Human TRAIL
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- > 3 mg/mL
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.
-
-
- TNFRSF10B (Drozitumab Biosimilar)
-
别名
- Drozitumab Biosimilar
-
物质类
- Biosimilar
抗原
-
You are here:
